Breast Implant Illness: A Way Forward.
Breast Implantation
/ adverse effects
Breast Implants
/ adverse effects
Female
Humans
Lymphoma, Large-Cell, Anaplastic
/ epidemiology
Needs Assessment
Patient Reported Outcome Measures
Prevalence
Prosthesis Failure
Risk Assessment
Silicone Gels
/ adverse effects
United States
/ epidemiology
United States Food and Drug Administration
Journal
Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
entrez:
1
3
2019
pubmed:
1
3
2019
medline:
4
4
2019
Statut:
ppublish
Résumé
The link between breast implants and systemic disease has been reported since the 1960s. Although many studies have looked at either supporting or refuting its existence, the issue still persists and has now been labeled "breast implant illness." The rise of patient advocacy and communication through social media has led to an increasing number of presentations to plastic surgeons. This article summarizes the history of breast implants and systemic disease, critically analyzes the literature (and any associated deficiencies), and suggests a way forward through systematic scientific study.
Identifiants
pubmed: 30817559
doi: 10.1097/PRS.0000000000005573
pii: 00006534-201903001-00012
doi:
Substances chimiques
Silicone Gels
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
74S-81SRéférences
Brody GSFact and fiction about breast implant “bleed.” Plast Reconstr Surg. 1977;60:615–616.
Baldwin CM Jr, Kaplan ENSilicone-induced human adjuvant disease? Ann Plast Surg. 1983;10:270–273.
Fischel EE, Kabat EA, Stoerk HC, et al.Suppression by cortisone of granuloma formation and antibody in guinea pigs receiving egg albumin with Freund adjuvants. J Allergy. 1954;25:195–200.
Stoerk HC, Bielinski TC, Budzilovich TChronic polyarthritis in rats injected with spleen in adjuvants. Am J Patho. 1954;30:616.
Pearson CMDevelopment of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med. 1956;91:95–101.
Chang YH, Pearson CMPathogenesis of adjuvant arthritis in rats. Arthritis Rheum. 1978;21:169–170.
Miyoshi K, Miyamura T, Kobayashi YHypergamma globulinemia by prolonged adjuvancity in man. Disorders developed after augmentation mammaplasty. Jap Med J. 1964;2122:9–14.
Kumagai Y, Abe C, Shiokawa YScleroderma after cosmetic surgery: four cases of human adjuvant disease. Arthritis Rheum. 1979;22:532–537.
van Nunen SA, Gatenby PA, Basten APost-mammoplasty connective tissue disease. Arthritis Rheum. 1982;25:694–697.
Sergott TJ, Limoli JP, Baldwin CM Jr, et al.Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg. 1986;78:104–114.
Fleischer MThe abundance and distribution of the chemical elements in the earth’s crust. J Chem Educ. 1954;31:446.
Luria LWThe role of medical grade silicones in surgery and its topical applications. Science. 2002;9:67–74.
Peters W, Keystone E, Snow K, et al.Is there a relationship between autoantibodies and silicone-gel implants? Ann Plast Surg. 1994;32:1–5; discussion 57.
Shoenfeld Y, Agmon-Levin N‘ASIA’ - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36:4–8.
Cohen Tervaert JW, Kappel RMSilicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld’s syndrome). Immunol Res. 2013;56:293–298.
Dush DMBreast implants and illness: a model of psychological factors. Ann Rheum Dis. 2001;60:653–657.
Weisman MH, Vecchione TR, Albert D, et al.Connective-tissue disease following breast augmentation: a preliminary test of the human adjuvant disease hypothesis. Plast Reconstr Surg. 1988;82:626–630.
Kaiser W, Biesenbach G, Stuby U, et al.Human adjuvant disease: remission of silicone induced autoimmune disease after explanation of breast augmentation. Ann Rheum Dis. 1990;49:937–938.
Press RI, Peebles CL, Kumagai Y, et al.Antinuclear autoantibodies in women with silicone breast implants. Lancet. 1992;340:1304–1307.
Bridges AJ, Conley C, Wang G, et al.A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med. 1993;118:929–936.
Schusterman MA, Kroll SS, Reece GP, et al.Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. Ann Plast Surg. 1993;31:1–6.
Gabriel SE, O’Fallon WM, Kurland LT, et al.Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med. 1994;330:1697–1702.
Sánchez-Guerrero J, Colditz GA, Karlson EW, et al.Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med. 1995;332:1666–1670.
Hennekens CH, Lee IM, Cook NR, et al.Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA. 1996;275:616–621.
Karlson EW, Lee IM, Cook NR, et al.Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals: the Women’s Health Cohort Study. Am J Epidemiol. 1999;150:652–660.
Rosenbaum JTLessons from litigation over silicone breast implants: a call for activism by scientists. Science. 1997;276:1524–1525.
Kaiser JScientific panel clears breast implants. Science. 1998;282:1963, 1965.
Bondurant S, Ernster V, Herdman RInstitute of Medicine (US) Committee on the Safety of Silicone Breast Implants; Safety of Silicone Breast Implants. 1999.Washington, DC: National Academies Press.
Tugwell P, Wells G, Peterson J, et al.Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel. Arthritis Rheum. 2001;44:2477–2484.
Janowsky EC, Kupper LL, Hulka BSMeta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med. 2000;342:781–790.
Food and Drug Administration. Surgery Devices Panel of the Medical Devices Advisory Committee. 2003. Available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfAdvisory/details.cfm?mtg=388. Accessed November 8, 2018.
Colaris MJL, de Boer M, van der Hulst RR, et al.Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature. Immunol Res. 2017;65:120–128.
Watad A, Rosenberg V, Tiosano S, et al.Silicone breast implants and the risk of autoimmune/rheumatic disorders: a real-world analysis. Int J Epidemiol. 2018;47:1846–1854.
Coroneos CJ, Selber JC, Offodile AC 2nd, et al.US FDA breast implant postapproval studies: long-term outcomes in 99,993 patients. Ann Surg. 2018;269:30–36.
Colwell AS, Mehrara BEditorial: US FDA breast implant postapproval studies-long-term outcomes in 99,993 patients. Ann Surg. 2018;269:39–40.
Ashar BStatement FDA Center for Devices and Radiological Health on agency’s commitment to studying breast implant safety. Available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620589.htm. Accessed November 8, 2018.
Collett D, Rakhorst H, Lennox P, et al.Current risk estimate of BIA-ALCL in textured breast implants. Plast Reconstr Surg. 2019. In press.
Peters W, Smith D, Fornasier V, et al.An outcome analysis of 100 women after explantation of silicone gel breast implants. Ann Plast Surg. 1997;39:9–19.
Rohrich RJ, Kenkel JM, Adams WP, et al.A prospective analysis of patients undergoing silicone breast implant explantation. Plast Reconstr Surg. 2000;105:2529–2537; discussion 25382543.
Netscher DT, Sharma S, Thornby J, et al.Aesthetic outcome of breast implant removal in 85 consecutive patients. Plast Reconstr Surg. 1997;100:206–219.
Netscher DTAesthetic outcome of breast implant removal in 85 consecutive patients. Plast Reconstr Surg. 2004;113:1057–1059.
Bravo FGParasternal infiltration composite breast augmentation. Plast Reconstr Surg. 2015;135:1010–1018.
Hamidian Jahromi ADetermining the oncologic safety of autologous fat grafting as a reconstructive modality: an institutional review of breast cancer recurrence rates and surgical outcomes. Plast Reconstr Surg. 2018;142:579e–580e.
Montemurro P, Porcnik A, Hedén P, et al.The influence of social media and easily accessible online information on the aesthetic plastic surgery practice: literature review and our own experience. Aesthetic Plast Surg. 2015;39:270–277.
Timberlake AT, Wu RT, Cabrejo R, et al.Harnessing social media to advance research in plastic surgery. Plast Reconstr Surg. 2018;142:1094–1100.
Tang SY, Israel JS, Poore SO, et al.Facebook facts: breast reconstruction patient-reported outcomes using social media. Plast Reconstr Surg. 2018;141:1106–1113.
Tang SY, Israel JS, Afifi AMBreast implant illness: symptoms, patient concerns, and the power of social media. Plast Reconstr Surg. 2017;140:765e–766e.
ABC. Beauty’s new normal. 2018. Available at https://www.abc.net.au/4corners/beautys-new-normal/10115838. Accessed November 2, 2018.
Cohen WA, Mundy LR, Ballard TN, et al.The BREAST-Q in surgical research: a review of the literature 2009-2015. J Plast Reconstr Aesthet Surg. 2016;69:149–162.
Loch-Wilkinson A, Beath KJ, Knight RJW, et al.Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140:645–654.
Hopper I, Ahern S, Best RL, et al.Australian Breast Device Registry: breast device safety transformed. ANZ J Surg. 2017;87:9–10.
Cooter RD, Barker S, Carroll SM, et al.International importance of robust breast device registries. Plast Reconstr Surg. 2015;135:330–336.